September 2021- Volume 17, Issue 9

In this Issue

Editors Insight

Resiliency in Science

Resiliency in Science

Resiliency in Science

Through research experience, scientists develop a strong sense of resiliency. The COVID-19 pandemic put that resiliency to the test, and now as vaccination rates increase and communities begin to open up, it’s time to take a breath.

Infectious Disease

The complex relationship between asthma and COVID-19

The complex relationship between asthma and COVID-19

The complex relationship between asthma and COVID-19

Respiratory viruses are the most common cause of asthma attacks, but COVID-19 does not send asthma patients to the hospital more often than others. Some researchers suspect that having asthma may actually protect patients from severe COVID-19.
Using CRISPR for Disease Eradication

Using CRISPR for Disease Eradication

Using CRISPR for Disease Eradication

Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.
A nasal spray for COVID-19

A nasal spray for COVID-19

A nasal spray for COVID-19

Experiments in ferrets show that a prophylactic spray cuts SARS-CoV-2 replication by more than 90 percent by priming the innate immune system.

Stem Cells

Stem cells jump-start the brain after a stroke

Stem cells jump-start the brain after a stroke

Stem cells jump-start the brain after a stroke

Transplanted astrocyte precursor cells promote healing in mouse brains after white matter strokes.

Aging

Prescribing art therapy for Parkinson's disease

Prescribing art therapy for Parkinson's disease

Prescribing art therapy for Parkinson's disease

Art therapy improved brain connectivity in patients with Parkinson’s disease, suggesting that creating art may help treat it and other neurodegenerative diseases.
Telomerase: the Protector of Chromosomes

Telomerase: the Protector of Chromosomes

Telomerase: the Protector of Chromosomes

Scientists found evidence of telomeres in the 1930s, but did not identify them until the 1970s. Since then, researchers’ understanding of telomeres and their role in DNA repair, aging, and disease has expanded exponentially.
Infographic: Antibody Therapy for Neurodegenerative Diseases

Infographic: Antibody Therapy for Neurodegenerative Diseases

Infographic: Antibody Therapy for Neurodegenerative Diseases

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Hematology

Genetically-engineered red blood cells help train T cells to fight tumors 

Genetically-engineered red blood cells help train T cells to fight tumors 

Genetically-engineered red blood cells help train T cells to fight tumors 

New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.
CAR T cell therapy gives glioblastoma patients hope

CAR T cell therapy gives glioblastoma patients hope

CAR T cell therapy gives glioblastoma patients hope

Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.
A new initiative for developing autologous stem cell therapies

A new initiative for developing autologous stem cell therapies

A new initiative for developing autologous stem cell therapies

A biopharmaceutical company established a new method for isolating and editing hematopoietic stem cells from patients to provide stem cell therapies for diseases such as sickle cell disease.
Subscribe to our eNewsletters

Stay connected with all the latest DDN news!

Latest Issue's Magazine Cover

Latest Issue  

• Volume 17 • Issue 9 • September 2021

September 2021

September 2021 Issue